EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation

Ahsan S Farooqi iD, B Ashleigh Guadagnolo, Devarati Mitra, Andrew J Bishop

Current Oncology · 03.01.2023 · 30 (1) · 598-609

DOI: 10.3390/curroncol30010047 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Oncology, online erschienen am 03.01.2023. Verfasst von Ahsan S Farooqi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unit 97, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Sarcoma, Soft Tissue Neoplasms, Retroperitoneal Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Locoregional recurrence (LRR) is the predominant pattern of relapse and often the cause of death in patients with retroperitoneal sarcomas (RPS). As a result, reducing LRR is a critical objective for RPS patients. However, unlike soft tissue sarcomas (STS) of the superficial trunk and extremity where the benefits of radiation therapy (RT) are well-established, the role of RT in the retroperitoneum remains controversial. Historically, preoperative or postoperative RT, either alone or in combination with intraoperative radiation (IORT), was commonly justified for RPS based on extrapolation from the superficial trunk and extremity STS literature. However, long-awaited results were recently published from the European Organization for Research and Treatment of Cancer (EORTC) STRASS study of preoperative radiotherapy plus surgery versus surgery alone for patients with RPS; there was no statistical difference in the primary endpoint of abdominal recurrence-free survival. However, several subset analyses and study limitations complicate the interpretation of the results. This review explores and contextualizes the body of evidence regarding RT’s role in managing RPS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcomaSoft Tissue NeoplasmsRetroperitoneal NeoplasmsHumansRadiotherapy, AdjuvantNeoplasm Recurrence, Local

Stichwörter der Autor:innen

radiation therapyretroperitoneal sarcomasurgery

Autor:innen und Institutionen

  • Unit 97, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.
  • Department of Health Services Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

ORCID-Profile: Ahsan S Farooqi

Förderung

  • NCATS NIH HHS

Zitieren

APA

Farooqi, A. S., Guadagnolo, B. A., Mitra, D., & Bishop, A. J. (2023). Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation. Current Oncology, 30(1), 598-609. https://doi.org/10.3390/curroncol30010047

Vancouver

Farooqi AS, Guadagnolo BA, Mitra D, Bishop AJ. Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation. Current Oncology. 2023;30(1):598-609. doi:10.3390/curroncol30010047

BibTeX
@article{Farooqi2023,
  author = {Farooqi, Ahsan S and Guadagnolo, B Ashleigh and Mitra, Devarati and Bishop, Andrew J},
  title = {Radiation Therapy for Retroperitoneal Sarcomas: A Strass-Ful Situation},
  journal = {Current Oncology},
  year = {2023},
  volume = {30},
  number = {1},
  pages = {598--609},
  doi = {10.3390/curroncol30010047}
}
Kostenlos starten →